namics of the pancreas as well as precise evaluation of the staining degree and the extent of pancreatic carcinoma.
It has been reported that since tumor vascularity is an important factor for determining cancer progression [3] , detailed evaluation of blood flow with contrast enhanced ultrasonography (CE-US) can have an impact on chemotherapy for pancreatic carcinoma and can be a prognostic predictor [4] .
While other diagnostic imaging techniques have shown poor blood flow in pancreatic carcinoma [5] , few studies have examined intratumoral microvessels and contrast enhanced staining. There have been no comparative studies of US and histology to examine the effect of histological factors on staining enhancement of CE-US.
The aim of the study was to clarify the relationship between intratumoral muscular arterial vessels and staining degree in CE-US.
SUBJECTS AND METHODS

Subjects
CE-US was performed on 84 consecutive patients with pancreatic carcinoma from September 2002 through June 2006 in Kurume University hospital. Surgical treatment was indicated and successfully performed in 13 cases, in which normal and cancerous regions of the pancreas were simultaneously delineated by CE-US and surgical enucleation was possible. They were 8 males and 5 females with a mean age of 64.8±7.5 years. These 13 patients with surgical specimens were enrolled in the study.
The tumor was located in the pancreas head, body or tail of the pancreas in 5, 7 and 1 patient, respectively. Tumor size averaged 24.4±12.5 mm in diameter. There were 2 well-differentiated adenocarcinomas, 8 moderately differentiated adenocarcinomas, 2 adenosquamous cell carcinomas, and 1 acinar cell carcinoma (Table 1 ). The study was performed according to the guidelines of the Helsinki Declaration. Informed consent was obtained from all patients.
CE-US examination
The coded harmonic angio mode of a GE LOGIQ 7 (General Electric Health Care, Milwaukee, Wisconsin, USA) ultrasonic scanner was used, transmitting at 2.2 MHz and receiving at 4.4 MHz. Acoustic power was at the default setting with a mechanical index of 0.6-1.2. The focus point was just below the bottom of the lesion. The US contrast agent Levovist, which is composed of 99.9% galactose and 0.1% palamic acid, was used in all patients. Levovist at 300 mg/ml (2.5 g) was administered intravenously at 1 ml/second, and after 10 to 15 seconds the patient was made to hold his or her breath during observation of the lesional area with a continuous transmission (7Hz). When the lesion and peripheral blood vessels were delineated, the transmission frequency was changed to 2 Hz and after observation of blood vessels intermittent transmission was performed for 2 to 4 seconds to obtain a perfusion image.
US Image Analysis
Following the completion of examination, using low data stored hard disk of the ultrasound observation device, regions of interest were established in cancerous and normal regions of the pancreas and time-72 CONTRAST-ENHANCED ULTRASONOGRAPHY IN PANCREATIC CANCER intensity curves (TIC) were generated (Fig. 1) . The percentage increase in brightness due to the contrast medium at maximum intensity and baseline intensity were quantified using the TIC, and pancreas intensity (PI) for normal tissue and tumor intensity (TI) for cancerous tissue were obtained. Quantitative assessment was performed using the formula; percentage brightness increase (%) = TI max -TI base/PI max -PI base ×100. Cases with a percentage brightness increase over 80% were allocated to the hyperperfusion group and those with a percentage brightness increase of less than 80% to the hypoperfusion group. The ultrasonic examinations were performed by two CE-US specialists.
Pathological examination
Resected specimens were examined by the same two pathologists. To determine the number of muscular arterial vessels, transverse sections of the largest part of the tumor were selected and stained with hematoxylin and eosin and double immunostained with α-SMA and anti-CD34. Under 200x magnification, the mean number of muscular arterial vessels in 10 fields was calculated and the mean microartery count (MAC) was obtained. The muscular arterial vessels were then classified by vessel diameter (>30 μm, 30>60 μm, 60 > _ 100 μm and > _ 100 μm), and the MACs were obtained for each classification.
Statistical analysis
Histological evaluation was performed using the Japan Pancreas Society classification [6] . Data are expressed as mean ± SD. 1) Percentage contrast increase and tissue images, 2) percentage contrast increase and MAC, and 3) percentage contrast increase and MAC by vessel diameter were examined. A P value of 0.05 was considered significant. All the analysis was done using JMP (SAS Institute, Cary, North Carolina, USA).
RESULTS
1) Percentage contrast increase and tissue images
Among the 6 cases in the hyperperfusion group, there were 2 well-differentiated tubular adenocarcinomas, 1 moderately differentiated tubular adenocarcinoma, 2 adenosquamous carcinomas and 1 acinar cell carcinoma (Fig. 2 ). All 7 cases in the hypoperfusion group were moderately differentiated tubular adenocarcinoma (Fig. 3) .
2) Percentage contrast increase and MAC
Muscular arterial vessel density evaluated by MAC was 9.2±5.4 (mean ± SD; P<0.05) in the hyperperfusion group, which was significantly higher than in Fig. 1-b . Percentage brightness increase was differentiated into maximum intensity and baseline intensity using the TIC, and PI and TI were obtained. Percentage brightness increase (%) = TI max -TI base/PI max -PI base × 100.
TIC,time intensity curve. PI, pancreas intensity. TI, tumor intensity. 
3) Percentage contrast increase and MAC by vessel diameter
MAC with a diameter of less than 30 μm was 7.2± 5.0 in the hyperperfusion group (P<0.05), which was significantly higher than in the hypoperfusion group (2.2±2.2) and normal pancreas (4.9±2.1). There was no significant difference between the MAC values in the 3 groups for vessels with a diameter of 30 to 60 μm and 60 to 100 μm.
For vessels with a diameter greater than 100 μm, MAC was 1.2±0.6 (P<0.05) in normal pancreas, which was significantly higher than the 0.6±1.0 in the hyperperfusion group and 0.4±0.7 in the hypoperfusion group (Table 2) .
In tubular adenocarcinoma the MAC for vessels with a diameter less than 30 μm was 9.5±5.5 (P<0.05) in well-differentiated adenocarcinoma, which was significantly higher than the 3.2±2.9 found in moderately differentiated adenocarcinoma (Table 3) .
No significant difference was observed in the amount of interstitial tissue in cancerous lesions between the hyperperfusion and hypoperfusion groups (Table 4) .
DISCUSSION
Imaging diagnostic methods show hypovascular tumors in pancreatic carcinoma and until now, the blood flow in tumors could not be delineated. Folkman proposed the idea that in solid tumors, the supply of oxygen and nutrients by diffusion limits the size of the tumor to approximately 250 to 300 μm [7] . His assumption was that unless angiogenesis occurred, a tumor could become no larger than 1 to 2 mm, and that vascularization was essential for tumor metastasis and enlargement. Following publication of these proposals, studies were undertaken to examine microvessel density (MVD), vascular endothelial growth factor (VEGF), thymidine phosphorylase (TP) and other angiogenesis factors, and there have also been reports of how their expression and mechanisms are related to angiogenesis [8] [9] [10] . MVD in particular is an indicator of the degree of angiogenesis and its use as a prognostic factor is anticipated [11] .
Many studies on the different prognoses of hyper vascular tumors by means of MVD were reported concerning breast cancer [12] , colon cancer [13] and gastric cancer [14] . Benckert et al. examined the correlation between MVD and VEGF and prognosis in pancreatic cancer, and reported that multivariable analysis showed high MVD to be an independent prognostic factor [15] . D'Onofrio et al. examined the relation between CE-US and angiogenesis and found a correlation between the contrast effect of CE-US and CD34-positive blood vessels pathologically examined in 42 pancreatic tumor patients [16] . There have, however, been only a few reports on the correlation between CE-US and MVD in pancreatic carcinoma, and a review of Pub Med and Japan Medical Abstracts Society found no reports on the direct correlation between CE-US and pathological findings. Until the advent of Levovist, US-angiography (US-A) was performed using carbon dioxide microbubbles injected into the hepatic artery as a contrast medium.
In pancreatic tumors, Koito et al. reported that US-A was superior to contrast CT and angiography for differentiating between mass forming pancreatitis and pancreatic ductal carcinoma [17] . However, angiographic examination is essential but highly invasive. On the other hand, Levovist enables intravenous evaluation of blood flow. Compared to other contrast agents, Levovist has not been reported to cause allergic reactions or renal disorders and seems to be an extremely safe contrast agent [18] . Furthermore, unlike the contrast medium used by CT, it is able to show a pure CE-US, contrast-enhanced ultrasonography.
CONTRAST-ENHANCED ULTRASONOGRAPHY IN PANCREATIC CANCER vessel image. Although pancreatic carcinoma is thought to be a hypovascular tumor, it should have some blood flow for growth. With US-A, the cancerous part of the pancreas is delineated as a poorly stained region [17] . Therefore, it was judged as hypovascular tumor. With CE-US, pancreatic tumors are shown distinctly and both sensitivity and specificity are high [19, 20] , because blood-flow evaluation is attained. There have also been reports of the usefulness of the staining patterns for tumor differentiation and for determining the surgical indication [1, 21] . In previous reports, however, the presence or absence of blood flow was determined visually and staining patterns were analyzed on that basis rather than by evaluating the degree of staining by intensity. We analyzed the TIC obtained by CE-US and compared the percentage brightness increase of the cancerous and normal parts of the pancreas. The results suggested that percentage brightness increase might be correlated with histological type in pancreatic carcinoma.
Differences in staining in US-A and CE-US are believed to be due to differences in bubble size (CO 2 > 30 μm, Levovist approximately 1.3 μm). This study showed that since there were many muscular arterial vessels with a diameter of less than 30 μm in cancerous parts, CO 2 bubbles could not pass through these blood vessels and they would therefore have been delineated as poorly stained areas. With Levovist, however, the vessels were delineated as stained areas. Therefore, the percentage of muscular arterial vessels less than 30 μm is the factor that determines the staining intensity in pancreatic cancer. As a result, with CE-US, quantitative evaluation of staining becomes an indirect evaluation of microvessel density, which could be a useful prognostic predictor for pancreatic carcinoma.
In conclusion, the CE-US density of muscular arterial vessels less than 30 μm is an important factor in determining staining degree and carcinoma progression in pancreatic carcinoma.
